ADVFN - ニュース

US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/08	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PSTV	Plus Therapeutics Inc
2024/06/08	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GPRO	GoPro Inc
2024/06/08	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACET	Adicet Bio Inc
2024/06/08	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BMEA	Biomea Fusion Inc
2024/06/08	05 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RXRX	Recursion Pharmaceuticals Inc
2024/06/08	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LION	Lionsgate Studios Corporation
2024/06/08	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:VTOL	Bristow Group Inc
2024/06/08	05 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TOL	Toll Brothers Inc
2024/06/08	05 : 01	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RCRTW	Recruiter com Group Inc
2024/06/08	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:UNH	UnitedHealth Group Inc
2024/06/08	05 : 01	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:KSCP	Knightscope Inc
2024/06/08	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QTRX	Quanterix Corporation
2024/06/08	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GEVO	Gevo Inc
2024/06/08	05 : 01	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:GOVXW	GeoVax Labs Inc
2024/06/08	05 : 01	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:APDN	Applied DNA Sciences Inc
2024/06/08	05 : 01	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:DRIO	DarioHealth Corporation
2024/06/08	05 : 01	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:FEMY	Femasys Inc
2024/06/08	05 : 01	Edgar (US Regulatory)	Form DEFM14A - Definitive proxy statement relating to merger or acquisition	NASDAQ:FFNW	First Financial Northwest Inc
2024/06/08	05 : 01	Edgar (US Regulatory)	Form 11-K - Annual report of employee stock purchase, savings and similar plans	NASDAQ:SKYW	SkyWest Inc
2024/06/08	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BWAQW	Blue World Acquisition Corporation
2024/06/08	05 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FPAY	FlexShopper Inc
2024/06/08	05 : 01	Business Wire	Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/06/08	05 : 01	Business Wire	Eaton Vance Municipal Bond Fund Announces Commencement of Tender Offer	AMEX:EIM	Eaton Vance Municipal Bond Fund
2024/06/08	05 : 01	Business Wire	Eaton Vance Municipal Bond Fund Announces Commencement of Tender Offer	NYSE:MS	Morgan Stanley
2024/06/08	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LMNR	Limoneira Company
2024/06/08	05 : 00	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:JSPRW	Jasper Therapeutics Inc
2024/06/08	05 : 00	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:RNAZ	TransCode Therapeutics Inc
2024/06/08	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPRX	OptimizeRx Corporation
2024/06/08	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SBFMW	Sunshine Biopharma Inc
2024/06/08	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INFN	Infinera Corporation

1 2 3 4 5 6 7 8 9 10 次へ >>

US Dollar vs Yen

Deutsche Telekom (QX)

Health Care Select Sector

Verizon Communications

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約